Item eligibility can change depending on the day of the week, time of day, and product availability, so please check each items availability at the time of order
Romosozumab carries a black box warning for increased cardiovascular risk, including heart attack, stroke, and cardiovascular death
Indication and important safety information INCRELEX (mecasermin) is indicated for the treatment of growth failure in pediatric patients aged 2 years and older with severe primary IGF-1 deficiency* (IGFD), or with hormone (GH) gene deletion who have developed neutralizing antibodies to GH
People taking semaglutide or tirzepatide often report a dramatic and almost immediate reduction in food thoughts and cravings
Glucagon-like peptide-1 receptor (GLP-1R) is a G protein-coupled receptor with a broad expression profile across various tissues, including the pancreas, heart, kidneys, blood vessels, liver, central nervous system and lungs [18]